ALDEYRA THERAPEUTICS INC stock forecast: down to 6.17 USD ALDX stock price prognosis

STOCK

Forecast for Fri 17 Nov 2023 price 6.40

ALDEYRA THERAPEUTICS INC stock price forecast for further price development down to -40.34% (time horizon: 1 day) and price target of 6.17 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ALDEYRA THERAPEUTICS INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol ALDX

ISIN US01438T1060

CUSIP 01438T106

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.40)

News <--> Close correlation for next day influence (-0.26)

Finance numbers

Earnings per share -1.11

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

We currently intend to commercialize our products directly or through collaborations. The response rate in patients with epithelial histology was 76%. Preclinical testing may continue even after the IND is submitted. Other conditions may also be imposed. Such post-approval trials are typically referred to as Phase 4 studies. The goal for completing a Priority Review is six months after acceptance of filing. This has the potential to complicate or prolong review of the application. 31 ITEM 1A. RISK FACTORS Our business is subject to numerous risks. This summary does not address all of the risks that we face. Average review times at the agency have fluctuated in recent years as a result. As a result, we may need to modify the way we treat such information. The failure by our management to apply these funds effectively could harm our business. Our quarterly operating results may fluctuate significantly. We intend to market our product candidates internationally. The failure to obtain these approvals could harm our business materially. Claims could also be asserted under state consumer protection acts. 61 We rely on third parties to conduct our clinical trials. We may not realize the benefits of our current or future strategic alliances. In addition, we rely on the protection of our trade secrets and proprietary know-how. We are subject to litigation risks.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1341235/000156459021012501/0001564590-21-012501.txt

Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

Meta analyst score 36.70/100

Good financial position.
Historical view, profit is growing.
Company revenue is not growing faster compared with the industry.
Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name	Date	Amount
A - BARCLAYS PLC	2023-06-30	126864
Knoll Capital Management, LLC	2023-06-30	3015668
NATIXIS	2022-12-31	44258
Parallax Volatility Advisers, L.P.	2022-12-31	13352
MetLife Investment Management, LLC	2022-03-31	14311

Fund ownership list is based on filling form information

Fund name	Date	Amount	Profile
Fidelity Concord Street Trust	2023-02-28	30129	Long
Fidelity Concord Street Trust	2023-02-28	248787	Long
Carillon Series Trust	2023-01-31	590889	Long
SCHWAB CAPITAL TRUST	2023-01-31	22201	Long
Fidelity Concord Street Trust	2023-01-31	17662	Long

Assets / Liabilities

Bollinger Bollinger Bands for ALDEYRA THERAPEUTICS INC can provide the information where the market is moving based on price information.

ALDEYRA THERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns ALDEYRA THERAPEUTICS INC.

On-Balance Volume information for ALDEYRA THERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for ALDEYRA THERAPEUTICS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for ALDEYRA THERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for ALDEYRA THERAPEUTICS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for ALDEYRA THERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for ALDEYRA THERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for ALDEYRA THERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High	52W Low	Market Cap

INFINITY PHARMACEUTICALS INC

News sentiment

Trend:

APTEVO THERAPEUTICS INC

News sentiment

ALDEYRA THERAPEUTICS INC on Nasdaq

ALDEYRA THERAPEUTICS INC on finviz

Figure below show the stock predictions.

Date	Closing price	Prediction was updated
2023-10-19	6.17	2023-09-23 16:48
2023-10-13	6.16	2023-09-23 16:48
2023-09-29	6.18	2023-09-23 16:48
2023-09-25	6.16	2023-09-23 16:48
2023-09-26	6.16	2023-09-23 16:48
2023-10-04	6.22	2023-09-23 16:48
2023-10-26	6.25	2023-09-23 16:48
2023-09-27	6.18	2023-09-23 16:48
2023-10-05	6.23	2023-09-23 16:48
2023-09-28	6.19	2023-09-23 16:48
2023-10-02	6.23	2023-09-23 16:48
2023-10-03	6.22	2023-09-23 16:48
2023-11-02	6.29	2023-09-23 16:48
2023-11-08	6.32	2023-09-23 16:48
2023-10-18	6.17	2023-09-23 16:48
2023-11-03	6.30	2023-09-23 16:48
2023-11-10	6.34	2023-09-23 16:48
2023-10-11	6.19	2023-09-23 16:48
2023-10-27	6.26	2023-09-23 16:48
2023-11-13	6.36	2023-09-23 16:48
2023-11-14	6.37	2023-09-23 16:48
2023-10-30	6.27	2023-09-23 16:48
2023-10-31	6.28	2023-09-23 16:48
2023-11-01	6.29	2023-09-23 16:48
2023-10-06	6.22	2023-09-23 16:48
2023-10-12	6.16	2023-09-23 16:48
2023-10-16	6.16	2023-09-23 16:48
2023-10-17	6.16	2023-09-23 16:48
2023-10-20	6.19	2023-09-23 16:48
2023-10-25	6.23	2023-09-23 16:48
2023-10-23	6.21	2023-09-23 16:48
2023-10-24	6.22	2023-09-23 16:48
2023-11-09	6.33	2023-09-23 16:48
2023-11-15	6.38	2023-09-23 16:48
2023-11-06	6.31	2023-09-23 16:48
2023-11-07	6.32	2023-09-23 16:48
2023-11-16	6.39	2023-09-23 16:48
2023-10-09	6.20	2023-09-23 16:48
2023-10-10	6.19	2023-09-23 16:48
2023-11-17	6.40	2023-09-23 16:48

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.